ESR1 and breast cancer: We identified two clusters, one which was mainly enriched in ER− breast cancer specimens (9 out of 12) and a second which was mainly enriched in ER+ breast cancer specimens (15 out of 22) (Pearson χ2, P<0.001), resulting in an accurate prediction of IHC ER status in 71% of the cases.